Literature DB >> 1955169

Decrease in two intestinal copper/zinc containing proteins with antioxidant function in inflammatory bowel disease.

T P Mulder1, H W Verspaget, A R Janssens, P A de Bruin, A S Peña, C B Lamers.   

Abstract

Oxygen derived radicals contribute to tissue injury in inflammatory bowel disease. We measured the content of superoxide dismutase and metallothionein (two endogenous copper and zinc containing proteins involved in radical scavenging) in intestinal resection specimens from 29 patients with Crohn's disease and 12 patients with ulcerative colitis and compared the concentrations with those obtained in the normal mucosa of a control group of 18 patients with colorectal cancer. The superoxide dismutase content was similar in control mucosa and non-inflamed mucosa from patients with inflammatory bowel disease (mean (SEM) 2.13 (0.10) and 2.24 (0.10) mg/g protein, respectively) but was decreased in inflamed mucosa (1.87 (0.08) mg/g protein, p less than 0.005 v non-inflamed mucosa). The metallothionein content was decreased in non-inflamed inflammatory bowel disease mucosa compared with control mucosa (0.23 (0.03) and 0.36 (0.04) mg/g protein, respectively, p less than 0.02) and a further decrease was found in inflamed mucosa (0.17 (0.02) mg/g protein, p less than 0.001 v control mucosa). No differences were found between Crohn's disease and ulcerative colitis and no significant effect of medication or tissue localisation was noted. These findings might indicate a decreased endogenous intestinal protection against oxygen derived radicals in inflammatory bowel disease which could contribute to the pathogenesis of the disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1955169      PMCID: PMC1379375          DOI: 10.1136/gut.32.10.1146

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  32 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  The immunocytochemical demonstration of metallothionein in human liver and small intestine.

Authors:  M E Elmes; J P Clarkson; B Jasani
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1986

Review 3.  Involvement of metallothionein in the hepatic metabolism of copper.

Authors:  I Bremner
Journal:  J Nutr       Date:  1987-01       Impact factor: 4.798

Review 4.  Metallothionein.

Authors:  M A Dunn; T L Blalock; R J Cousins
Journal:  Proc Soc Exp Biol Med       Date:  1987-06

5.  5-Aminosalicylate: oxidation by activated leukocytes and protection of cultured cells from oxidative damage.

Authors:  B J Dull; K Salata; A Van Langenhove; P Goldman
Journal:  Biochem Pharmacol       Date:  1987-08-01       Impact factor: 5.858

6.  Xanthine oxidase and neutrophil infiltration in intestinal ischemia.

Authors:  M B Grisham; L A Hernandez; D N Granger
Journal:  Am J Physiol       Date:  1986-10

7.  Possible role for metallothionein in protection against radiation-induced oxidative stress. Kinetics and mechanism of its reaction with superoxide and hydroxyl radicals.

Authors:  P J Thornalley; M Vasák
Journal:  Biochim Biophys Acta       Date:  1985-01-21

8.  Effect of sulphasalazine and its metabolites on the generation of reactive oxygen species.

Authors:  Y Miyachi; A Yoshioka; S Imamura; Y Niwa
Journal:  Gut       Date:  1987-02       Impact factor: 23.059

9.  Sulfasalazine and its metabolites attenuate respiratory burst of leukocytes--a possible mechanism of anti-inflammatory effects.

Authors:  M Suematsu; M Suzuki; S Miura; H Nagata; C Oshio; H Asakura; M Watanabe; M Tsuchiya
Journal:  J Clin Lab Immunol       Date:  1987-05

Review 10.  Alteration of radiosensitivity in metallothionein induced mice and a possible role of Zn-Cu-thionein in GSH-peroxidase system.

Authors:  J Matsubara
Journal:  Experientia Suppl       Date:  1987
View more
  31 in total

1.  Total antioxidant capacity of colon in patients with chronic ulcerative colitis.

Authors:  T R Koch; L X Yuan; S J Stryker; P Ratliff; G L Telford; E C Opara
Journal:  Dig Dis Sci       Date:  2000-09       Impact factor: 3.199

2.  Metallothionein genes: no association with Crohn's disease in a New Zealand population.

Authors:  Angharad R Morgan; Alan G Fraser; Lynnette R Ferguson
Journal:  J Negat Results Biomed       Date:  2012-01-28

3.  Direct evidence of oxidative damage in acute and chronic phases of experimental colitis in rats.

Authors:  C Loguercio; G D'Argenio; M Delle Cave; V Cosenza; N Della Valle; G Mazzacca; C del Vecchio Blanco
Journal:  Dig Dis Sci       Date:  1996-06       Impact factor: 3.199

4.  Treatment of Helicobacter pylori infection favourably affects gastric mucosal superoxide dismutases.

Authors:  J M Götz; J L Thio; H W Verspaget; G J Offerhaus; I Biemond; C B Lamers; R A Veenendaal
Journal:  Gut       Date:  1997-05       Impact factor: 23.059

5.  Erythrocyte deformability and oxidative stress in inflammatory bowel disease.

Authors:  Tulay Akman; Mesut Akarsu; Hale Akpinar; Halil Resmi; Ebru Taylan; Ebru Sezer
Journal:  Dig Dis Sci       Date:  2011-09-08       Impact factor: 3.199

6.  Relation between colonic inflammation severity and total low-molecular-weight antioxidant profiles in experimental colitis.

Authors:  S Blau; R Kohen; P Bass; A Rubinstein
Journal:  Dig Dis Sci       Date:  2000-06       Impact factor: 3.199

7.  Differences in the reducing power along the rat GI tract: lower antioxidant capacity of the colon.

Authors:  S Blau; A Rubinstein; P Bass; C Singaram; R Kohen
Journal:  Mol Cell Biochem       Date:  1999-04       Impact factor: 3.396

Review 8.  Zinc and gastrointestinal disease.

Authors:  Sonja Skrovanek; Katherine DiGuilio; Robert Bailey; William Huntington; Ryan Urbas; Barani Mayilvaganan; Giancarlo Mercogliano; James M Mullin
Journal:  World J Gastrointest Pathophysiol       Date:  2014-11-15

9.  Decreased total and corrected antioxidant capacity in patients with inflammatory bowel disease.

Authors:  Ioannis E Koutroubakis; Niki Malliaraki; Philippos D Dimoulios; Konstantinos Karmiris; Elias Castanas; Elias A Kouroumalis
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

10.  Balsalazine decreases intestinal mucosal permeability of dextran sulfate sodium-induced colitis in mice.

Authors:  Xiao-Chang Liu; Qiao Mei; Jian-Ming Xu; Jing Hu
Journal:  Acta Pharmacol Sin       Date:  2009-07       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.